MOL heads into the final week of September with an unusual insider dynamic: a board director just made a sizeable open-market purchase even as other executives were selling — and the stock sits barely flat on the week at HUF 5,150.
The most notable development is the board-level buy. Zsigmond Járai, a member of MOL's board of directors, acquired 137,000 shares on September 22-23, paying roughly EUR 99.48 per share for a total consideration equivalent to approximately $13.6 million. That is a meaningful commitment from a non-executive director, and it stands out against the backdrop of two executive sales earlier in the month. On September 14, Group Downstream EVP Gabriel Szabó sold nearly 30,000 shares at around HUF 5,355. Two days later, Group Exploration and Production EVP Zsombor Marton sold 60,731 shares at HUF 5,203, raising roughly HUF 316 million. Combined, the 90-day net insider position is modestly negative in share terms — a net reduction of around 31,000 shares — though the Járai purchase injects a contrarian signal into the mix. Executive sales at a Hungarian integrated oil major often reflect compensation-driven liquidity rather than directional conviction, and neither sale arrived at a distressed price.
The short-selling community shows little interest in pressing MOL lower. Borrow availability is extraordinarily loose — well above 7,000% of short interest, meaning shares available to lend dwarf what is currently borrowed — and that reading has been near the top of its 52-week range for most of the past month. The cost to borrow is negligible at around 0.74%, and short interest is tiny relative to the float. None of the usual pressure metrics are flashing. The ORTEX short score of 25.7 ranks in the 93rd percentile for low short pressure — a reading that has barely moved across the past two weeks, reinforcing the picture of a stock with minimal speculative short interest.
What the Street does show is quiet, durable bullishness at a cheap valuation. Seven analysts carry buy or outperform ratings on MOL, with no sell ratings in the current consensus. The mean price target of around HUF 4,961 sits marginally below Thursday's close of HUF 5,150 — worth flagging as a potential stale data artefact, given the stock has traded through the consensus target. The valuation picture is genuinely cheap: a PE of roughly 7.2x, EV/EBITDA near 3.2x, and price-to-book below 1x. The EPS momentum factor scores rank in the 87th and 91st percentiles on 30-day and 90-day windows respectively, and the dividend score sits in the 95th percentile — MOL paid a HUF 317.58 cash dividend in September 2026 and proposed a HUF 120 special dividend for 2025, adding a meaningful income angle.
MOL's earnings history around recent prints has been benign. After the August 2026 results, the stock gained 1.4% on the day and extended to nearly 7% over the following five days. The May 2026 print produced a 1.1% one-day decline and a 3.9% five-day pullback. The pattern is modest moves in both directions — no history of dramatic gap risk. The next event is scheduled for November 6, giving the market roughly six weeks before the next data point.
Nearest regional peer PKN on the Warsaw Stock Exchange fell 0.9% on Thursday and is down 1.5% on the week, broadly matching MOL's flat weekly performance. The convergence of cheap multiples, a high dividend score, benign borrow conditions, and a board director buying at current levels sets up the November earnings date as the next real test of whether the gap between the stock's price and its factor positioning begins to close.
See the live data behind this article on ORTEX.
Open MOL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
